EMBARGOED FOR RELEASE: 11 A.M. (ET), TUESDAY, JUNE 19, 2018
Want to embed a link to this article in your story? Link will be live at the embargo time: http://jamanetwork.com/journals/jama/fullarticle/10.1001/jama.2018.6798
Bottom Line: A JAMA Clinical Guidelines Synopsis article examines the American College of Physicians’ (ACP’s) 2018 guidance statement on HbA1c goals in nonpregnant adults with type 2 diabetes, including the possible effect of a recommended HbA1c level between 7 percent and 8 percent for most patients with type 2 diabetes, a range that is higher than other guidelines.
Authors: Elizabeth L. Tung, M.D., M.S., University of Chicago, and coauthors
To Learn More: The full article is available on the For The Media website.
Editor’s Note: Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, funding and support, etc.
The following related elements from The JAMA Network are also available on the For The Media website:
— A summary video, “Hemoglobin A1c Targets in Type 2 Diabetes,” is available for download or to embed on your website. Download the video as a high-quality MP4 file by clicking on this link and then right-clicking and selecting “save video as.” In addition, you may copy and paste the html code below to embed the video on your website.
— A podcast, “A Goal Too Far: Rethinking HbA1c Targets for Diabetes Treatment,” is available for listening and download on this page.
— In JAMA’s From The Medical Letter on Drugs and Therapeutics section, the article “Ertugliflozin for Type 2 Diabetes.”
— The JAMA Medical News & Perspectives article, “For Patients With Type 2 Diabetes, What’s the Best Target Hemoglobin A1C?”
Video embed code: